Subdermal Contraceptive Implants Market Size Worth $973.5 Million By 2028 | CAGR: 3.4%

Subdermal Contraceptive Implants Market Size Worth $973.5 Million By 2028 | CAGR: 3.4%

The global subdermal contraceptive implants market size is expected to reach USD 973.5 million by 2028 according to a new study by Polaris Market Research. The report “Subdermal Contraceptive Implants Market Share, Size, Trends, Industry Analysis Report, By Product (Levonorgestrel Implant, Etonogestrel Implant, Others); By End-Use (Hospitals, Clinics, Diagnostic Centers, Others); By Regions; Segment Forecast, 2021 - 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.


The demand for subdermal contraceptive implants is expected to increase during the forecast period owing to increasing awareness regarding sexual health, rising cases of unwanted pregnancies, and government regulations regarding population control. Technological advancements, the introduction of affordable implants, and a growing population drive the market growth.


The market demand for etonogestrel subdermal contraceptive implants was high in 2020. Etonogestrel implants are the long-term contraceptive solution, implanted under the skin of the upper arm. The increasing population, growing initiatives for population control, rising concerns regarding sexual health, and increasing healthcare expenditure in developing countries, such as India, China, and Japan, boost the adoption of subdermal contraceptive implants.


Subdermal contraceptive implants are used in diagnostic centers, hospitals, clinics, and others. The hospital segment accounted for the highest share in 2020. Availability of advanced healthcare infrastructure and the growing need to offer high-quality healthcare services drives the growth of this segment. Governments across the globe are introducing programs and awareness campaigns for population control through collaboration with hospitals, resulting in increased adoption of these implants.


Have Questions? Request a sample or make an inquiry before buying this report by clicking the link below:


North America dominated the global market for subdermal contraceptive implants in 2020 and is expected to maintain its dominance over the forecast period. High disposable income, the presence of leading market players, and technological advancements support the market growth in this region. Supportive government regulations and the presence of well-established healthcare infrastructure further increases the demand for subdermal contraceptive implants in North America.


Asia Pacific market for subdermal contraceptive implants is expected to experience significant growth during the forecast period owing to increasing health awareness, rising spending on healthcare, and significant government schemes. Leading global market players are expanding their presence in developing nations of China, Japan, India, and South Korea to tap the growth opportunities offered by these countries.


On account of the technological advancements, and greater need to cater to customer requirements, companies are collaborating in order to strengthen the market presence and gain subdermal contraceptive implants industry share. Broadening of the product portfolio is another trend that is visible in the industry.


Some of the major market participants in subdermal contraceptive implants industry include Karex Industries, Bayer AG, Teva Pharmaceutical Industries Ltd., KESSEL medintim GmbH, Allergan plc, Shanghai Dahua Pharmaceutical Co., Ltd., The Female Health Company, Reckitt Benckiser Group plc, Merck & Co., Inc., and Mayer Laboratories.


Polaris Market Research has segmented the subdermal contraceptive implants market report on the basis of product, end-use, and region:


Subdermal Contraceptive Implants Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Levonorgestrel Implant
  • Etonogestrel Implant
  • Others

Subdermal Contraceptive Implants End-User Outlook (Revenue, USD Million, 2016 - 2028)

  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Others

Subdermal Contraceptive Implants Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • RoE
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
    • Colombia
    • RoLATAM
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Israel
    • UAE
    • RoMEA